European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading

MT Newswires Live08-06 23:18

European equities traded in the US as American depositary receipts were heading higher late Thursday morning, rising 0.85% to 1,947.79 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and pharmaceutical company Ascendis Pharma (ASND), which advanced 4.8% and 2.2% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA) and internet ad firm Criteo (CRTO), which were up 1.7% and 0.9% respectively.

The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which dropped 2.3% and 2.1% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and biotech company Evaxion (EVAX), which lost 1.8% and 1.3% respectively.

The gainers from the UK were led by communications company WPP (WPP) and biotech firm Trinity Biotech (TRIB), which surged 26% and 11% respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and alcoholic beverage company Diageo (DEO), which rose 5.3% and 4.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and medical device maker Smith & Nephew (SNN), which fell 4.4% and 1.9% respectively. They were followed by educational publisher Pearson (PSO) and biopharmaceutical company Mereo BioPharma Group (MREO), which were down 1.6% and 1.2% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment